{"gene":"PRKCG","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":1997,"finding":"PKCγ-null mice display normal acute pain responses but fail to develop neuropathic pain after partial sciatic nerve section, establishing PKCγ as required for injury-induced persistent pain sensitization. PKCγ was found restricted to a small subset of dorsal horn interneurons.","method":"PKCγ knockout mouse model, behavioral pain testing, neurochemical analysis","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — clean KO with specific phenotypic readout, replicated across multiple pain paradigms","pmids":["9323205"],"is_preprint":false},{"year":2001,"finding":"PKCγ mediates the transition from short-term to long-term hyperexcitability of lamina V nociresponsive neurons after tissue injury (mustard oil). Wild-type mice showed progressive enhancement of wide dynamic range neuron responses while PKCγ-null mice showed hyperexcitability lasting <30 min. PKCγ contributes to a subset of NMDA-dependent spinal circuits underlying persistent pain.","method":"Electrophysiological recordings and behavioral assays in PKCγ-null vs wild-type mice, NMDA receptor antagonist pharmacology","journal":"The Journal of Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — reciprocal electrophysiology and behavior in KO vs WT, NMDA antagonist epistasis","pmids":["11438608"],"is_preprint":false},{"year":2002,"finding":"PKCγ mediates phosphorylation of the cytoplasmic domain of syndecan-2 in right (but not left) ectodermal cells during Xenopus gastrulation, and this asymmetric phosphorylation is required for left-right development via syndecan-2-mediated inside-out signaling to adjacent migrating mesodermal cells.","method":"In vivo phosphorylation assays, dominant-negative/constitutively active PKCγ constructs, animal cap ectodermal cell experiments in Xenopus","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 — direct phosphorylation assay with functional rescue/LOF, published in Cell","pmids":["12507425"],"is_preprint":false},{"year":2003,"finding":"IGF-I activates and translocates PKCγ in lens epithelial cells, leading to coimmunoprecipitation with and phosphorylation of connexin 43 (Cx43), resulting in decreased gap junction activity. IGF-I increases endogenous DAG which triggers PKCγ translocation; calcium mobilization is not essential for this effect.","method":"Western blot, co-immunoprecipitation, PKC translocation assay, in vitro PKC phosphorylation assay, scrape-loading/dye-transfer gap junction assay, confocal microscopy","journal":"Investigative Ophthalmology & Visual Science","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro kinase assay, co-IP, and functional gap junction assay in same study","pmids":["12601045"],"is_preprint":false},{"year":2004,"finding":"14-3-3ε binds the C1B domain of PKCγ at two sites (C1B1: residues 101-112 and C1B5: residues 141-151) to inhibit PKCγ activity. Synthetic peptides corresponding to these sites compete for 14-3-3ε binding, releasing PKCγ, causing its phosphorylation and membrane translocation, which leads to Cx43 phosphorylation and inhibition of gap junction activity.","method":"In vitro and in vivo competition binding assays with synthetic peptides, co-immunoprecipitation, PKC enzyme activity assay, gap junction dye-transfer assay, HPLC, MALDI-TOF MS","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — peptide competition with binding site identification, in vitro and in vivo, functional assay","pmids":["15459208"],"is_preprint":false},{"year":2005,"finding":"Activation of PKCγ by phorbol ester (TPA) in rat lens disassembles Cx50 gap junction channels: PKCγ translocates to membrane fractions containing Cx46, Cx50, and caveolin-1, phosphorylates Cx50 at serines and threonines, and Cx46 only at threonines, leading to decreased Cx50 channel density in gap junctions and increased Cx50 hemichannels in plasma membrane.","method":"Freeze-fracture immunolabeling (FRIL), dye-transfer assay, PKCγ activity assay, connexin phosphorylation, co-immunoprecipitation","journal":"Investigative Ophthalmology & Visual Science","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods; direct kinase activity, phosphorylation and structural imaging","pmids":["16123426"],"is_preprint":false},{"year":2005,"finding":"The SCA14 H101Q mutation in PRKCG causes decreased PKCγ protein levels in HEK293 cells over time (affecting stability/solubility), leading to reduced PKCγ-dependent phosphorylation and slowly progressive cerebellar ataxia.","method":"Transfection of HEK293 cells with normal or mutant construct, time-dependent protein level measurements by Western blot","journal":"Journal of Human Genetics","confidence":"Medium","confidence_rationale":"Tier 2 — functional study in transfected cells; single lab","pmids":["16189624"],"is_preprint":false},{"year":2008,"finding":"PKCγ interneurons of the spinal dorsal horn are activated by myelinated afferents (VGLUT1-expressing) that respond to innocuous stimuli, not by unmyelinated nociceptors. VGLUT1 synapses were shown pre-synaptic to PKCγ interneurons by electron microscopy, and walking on a rotarod induced Fos in PKCγ interneurons.","method":"Transganglionic tracer studies (cholera toxin B, wheat germ agglutinin), transneuronal tracer, light and electron microscopic double labeling, VGLUT1 immunohistochemistry, Fos induction assay","journal":"The Journal of Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal anatomical methods, electron microscopy, functional Fos assay","pmids":["18685019"],"is_preprint":false},{"year":2008,"finding":"NMDAR/nNOS cascade activated by morphine provides free zinc ions that recruit inactive PKCγ (via its C1/CRD domain) to the HINT1/RGSZ complex at the C-terminus of the mu-opioid receptor (MOR). DAG then activates this PKCγ to phosphorylate the MOR, reducing its signaling strength. HINT1 knockdown abolishes PKCγ-MOR association and serine phosphorylation of MOR.","method":"Intracerebroventricular administration, co-immunoprecipitation, antisense knockdown of HINT1, zinc chelation (TPEN), NMDAR antagonist (MK801), NO donor experiments","journal":"Cellular Signalling","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP, pharmacological epistasis, multiple conditions; single lab","pmids":["18652891"],"is_preprint":false},{"year":2009,"finding":"Activation of PKCγ by phorbol ester potentiates AMPA receptor-mediated mEPSC amplitude in embryonic zebrafish via NSF- and PICK1-dependent AMPAR trafficking. This process requires DAG, Ca2+, active PKCγ, actin polymerization, SNARE proteins, and GluR2 association with both NSF and PICK1.","method":"Whole-cell patch-clamp recordings, pharmacological blockade with blocking peptides (NSF, PICK1, GluR2), actin-polymerization blocker, tetanus toxin","journal":"PNAS","confidence":"Medium","confidence_rationale":"Tier 2 — electrophysiology with multiple peptide/pharmacological tools; zebrafish ortholog","pmids":["19366675"],"is_preprint":false},{"year":2010,"finding":"VEGF activates PKCγ through a Src-dependent PLD1 pathway in human retinal microvascular endothelial cells. Inhibition of Src, PLD1, or PKCγ via pharmacologic, dominant negative, or siRNA approaches significantly attenuated VEGF-induced endothelial cell migration, proliferation, and tube formation, as well as hypoxia-induced retinal neovascularization.","method":"siRNA knockdown, dominant negative mutants, pharmacological inhibitors, endothelial cell migration/proliferation/tube formation assays, in vivo retinal neovascularization model","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal inhibition strategies (pharmacological, dominant negative, siRNA) with in vitro and in vivo validation","pmids":["20421451"],"is_preprint":false},{"year":2010,"finding":"Mutant PKCγ (S119P) associated with SCA14 aggregates in Purkinje cells, impairs climbing fiber synapse pruning, blocks long-term depression (LTD) at parallel fiber synapses, and increases slow EPSC amplitude. Mutant PKCγ colocalizes with and acts in a dominant-negative manner on wild-type PKCγ, and decreases membrane residence time of PKCα after depolarization-induced translocation.","method":"Lentiviral expression of mutant PKCγ-GFP in mouse Purkinje cells in vivo, electrophysiology (LTD, EPSCs, CF synapse pruning), immunohistochemistry","journal":"The Journal of Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — in vivo loss/gain of function with electrophysiological and morphological readouts, multiple mechanisms identified","pmids":["21976518"],"is_preprint":false},{"year":2010,"finding":"Mutant PKCγ causing SCA14 is selectively degraded by autophagy. Rapamycin (autophagic inducer) accelerated clearance of mutant (but not wild-type) PKCγ aggregates, an effect absent in Atg5-deficient cells that cannot perform autophagy.","method":"Adenoviral tetracycline-regulated expression system, rapamycin and lithium treatment, Atg5-knockout fibroblasts as genetic control, aggregate clearance and protein degradation assays","journal":"Genes to Cells","confidence":"Medium","confidence_rationale":"Tier 2 — genetic (Atg5 KO) and pharmacological validation in cell models","pmids":["20398063"],"is_preprint":false},{"year":2011,"finding":"PKCγ is required for ethanol-induced increases in GABA(A) receptor α4 subunit expression in cultured cortical neurons. PKCγ siRNA knockdown prevented ethanol-induced α4 upregulation, while PKCβ isoform inhibition had no effect.","method":"siRNA knockdown of PKCγ vs PKCβ pseudosubstrate inhibition, P2 fractionation, surface biotinylation, whole-cell patch clamp","journal":"Journal of Neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — isoform-selective siRNA knockdown with functional assay and electrophysiology","pmids":["21155805"],"is_preprint":false},{"year":2011,"finding":"NO-released zinc ions recruit both Raf-1 and PKCγ via their cysteine-rich domains (CRDs) simultaneously to HINT1 at the MOR C-terminus. PKCγ enhances Raf-1 function to amplify MEK/ERK1/2 activation at the MOR. Morphine-generated NO mediates this cross-talk between PKC/Src and Raf-1/ERK1/2 pathways implicated in negative control of morphine effects.","method":"Co-immunoprecipitation, TPEN zinc chelation, MK801 NMDAR blockade, A-Raf/B-Raf comparison, in vivo intracerebroventricular administration","journal":"Antioxidants & Redox Signaling","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP with multiple pharmacological controls; single lab","pmids":["21235400"],"is_preprint":false},{"year":2011,"finding":"cPLA2 is an effector downstream of Src-PLD1-PKCγ signaling in VEGF-induced retinal angiogenesis. Inhibition of Src, PLD1, or PKCγ attenuated VEGF-induced cPLA2 phosphorylation and arachidonic acid release, and exogenous arachidonic acid rescued endothelial function from cPLA2 siRNA inhibition.","method":"siRNA knockdown, pharmacological inhibition, cPLA2 phosphorylation assay, arachidonic acid release assay, in vivo retinal neovascularization model","journal":"The Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — ordered epistasis by siRNA and rescue experiment, in vitro and in vivo","pmids":["21536681"],"is_preprint":false},{"year":2012,"finding":"PKCγ participates in food-mediated circadian entrainment by stabilizing BMAL1 and reducing its ubiquitylation in a deubiquitination-dependent manner. PKCγ-null mice failed to show reduced late-night activity in response to daytime restricted feeding, and PKCγ exhibited food-entrainment-induced activation changes in cerebral cortex.","method":"PKCγ knockout mice, behavioral analysis, molecular analysis of clock gene oscillations, BMAL1 stability and ubiquitylation assays","journal":"PNAS","confidence":"Medium","confidence_rationale":"Tier 2 — KO phenotype with molecular mechanism (BMAL1 stabilization); single lab","pmids":["23185022"],"is_preprint":false},{"year":2014,"finding":"PKCγ directly phosphorylates βPIX (Pak-interacting exchange factor-β) at Ser583 and indirectly at Ser340 in cells, and this phosphorylation is required for Ca2+-evoked dopamine release in the striatum. PKCγ-KO mice show parkinsonian syndrome with impaired striatal dopamine release.","method":"PKCγ-KO mice, phosphoproteome analysis, in vitro kinase assay (direct phosphorylation), βPIX knockdown with rescue by wild-type vs phospho-site mutants, Ca2+-evoked dopamine release assay in PC12 cells","journal":"The Journal of Neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — direct in vitro kinase assay with mutagenesis, in vivo KO phenotype, and rescue experiment","pmids":["25009260"],"is_preprint":false},{"year":2014,"finding":"EGF activates PLCγ1, which signals through Ca2+ and PKCγ to promote plasma membrane translocation of Hsp90α. PKCγ overexpression increases extracellular vesicle release containing Hsp90α and promotes tumor cell motility and metastasis in vitro and in vivo; a neutralizing antibody against Hsp90α blocks these PKCγ-induced effects.","method":"siRNA knockdown, PKCγ overexpression, inhibitor studies, in vitro migration assays, in vivo tumor metastasis model, neutralizing antibody","journal":"Traffic","confidence":"Medium","confidence_rationale":"Tier 2 — multiple inhibition and overexpression strategies; single lab","pmids":["24899266"],"is_preprint":false},{"year":2014,"finding":"PKCγ was identified as an amyloidogenic protein capable of forming amyloid-like fibrils in vitro without heat or chemical denaturants, via its C1A and kinase domains. SCA14-associated mutations accelerate amyloid-like fibril formation both in cells and in vitro, and long-term imaging shows aggregates of mutant PKCγ are highly toxic to neuronal cells.","method":"In vitro incubation without denaturants, overexpression in cultured cells, live cell time-lapse imaging, identification of amyloid-prone domains by domain deletion","journal":"Human Molecular Genetics","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution of fibril formation with domain mapping and cell toxicity validation","pmids":["25217572"],"is_preprint":false},{"year":2016,"finding":"LysoPCs activate PKCγ through a sequential Hck→PKCδ→PKCγ cascade: Hck causes Tyr311/Tyr525 phosphorylation and Thr507 phosphorylation of PKCδ; activated PKCδ then causes Tyr514 and Ser phosphorylation of PKCγ; activated PKCγ then causes phosphorylation and membrane translocation of p47phox. PKCγ-KO PMNs failed to show PKCδ-PKCγ FRET interaction or priming by lysoPCs.","method":"Immunoprecipitation, FRET (fluorescence resonance energy transfer), immunoblotting, specific kinase inhibitors, PKCγ KO mice, TRALI in vivo model, intracellular PKC isoform depletion","journal":"Journal of Leukocyte Biology","confidence":"High","confidence_rationale":"Tier 2 — FRET-confirmed protein interaction, genetic KO validation, ordered pathway with phospho-site identification","pmids":["27531930"],"is_preprint":false},{"year":2018,"finding":"SCA14 mutations in the C1 domain of PKCγ (H36R and H101Q) cause cytoplasmic mislocalization, aggregation, and hyper-activation of PKCγ (increased substrate phosphorylation). PKCγ aggregates are not efficiently targeted for degradation. Both loss-of-function and gain-of-function mechanisms contribute to SCA14 pathogenesis.","method":"Patient-derived iPSCs, post-mortem SCA14 cerebellum, immunohistochemistry, substrate phosphorylation assays, protein localization studies","journal":"Acta Neuropathologica Communications","confidence":"High","confidence_rationale":"Tier 2 — patient material (post-mortem and iPSCs) with functional phosphorylation assays, two mutations studied","pmids":["30249303"],"is_preprint":false},{"year":2018,"finding":"Endogenous Hsp70 is incorporated into SCA14-associated PKCγ aggregates. PKCγ binds Hsp70 via its kinase domain and C2 domain, with enhanced interaction in SCA14 mutants. Pharmacological up-regulation of Hsp70 (by Hsp90 inhibitors celastrol/herbimycin A) attenuates mutant PKCγ aggregation and apoptosis in Purkinje cells.","method":"Co-immunoprecipitation, domain mapping, primary cultured Purkinje cells, Hsp90 inhibitor treatment, apoptosis assay, in vivo celastrol administration","journal":"The Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP with domain mapping and functional rescue; single lab","pmids":["30093405"],"is_preprint":false},{"year":2019,"finding":"PKCγ promotes axonal remodeling in the corticospinal tract by phosphorylating GSK3β, which stabilizes cytosolic β-catenin and increases GAP43 expression, facilitating neuronal differentiation, neurite outgrowth, and axonal branching. In vivo rAAV2/9-mediated delivery of constitutively active PKCγ to CST after unilateral TBI promoted midline crossing of corticospinal fibers and sensorimotor recovery.","method":"Loss- and gain-of-function in N2a cells and primary cortical neurons, GSK3β phosphorylation assays, β-catenin and GAP43 Western blot, rAAV2/9 in vivo delivery, axonal tracing, behavioral assays","journal":"Scientific Reports","confidence":"Medium","confidence_rationale":"Tier 2 — signaling pathway epistasis with in vitro and in vivo validation; single lab","pmids":["31745212"],"is_preprint":false},{"year":2019,"finding":"ΔNp63α positively regulates miR-320a, which suppresses PKCγ expression. Loss of ΔNp63α elevates PKCγ levels, increasing Rac1 phosphorylation at Ser71 and cell invasion. Silencing PKCγ or inhibiting PKC reversed increased Rac1 phosphorylation and invasion caused by ΔNp63α knockdown.","method":"siRNA knockdown, miRNA mimic overexpression, PKC inhibitor (Gö6976), Rac1 silencing, invasion assays","journal":"Cell Death & Disease","confidence":"Medium","confidence_rationale":"Tier 2 — ordered pathway validated by multiple knockdown strategies; single lab","pmids":["31515469"],"is_preprint":false},{"year":2020,"finding":"DGKγ directly interacts with PKCγ, converts diacylglycerol to phosphatidic acid, and thereby negatively regulates PKCγ activity. DGKγ knockout mice show upregulated PKCγ activity in cerebellum, impaired cerebellar LTD, retracted Purkinje cell dendrites, and impaired motor coordination. cPKC inhibitor rescues dendritic retraction; PKCγ-specific inhibitor (scutellarin) rescues LTD.","method":"DGKγ KO mice, Purkinje cell-specific DGKγ KO (tm1d), PKCγ activity assays, cerebellar LTD electrophysiology, dendritic morphology analysis, rescue with Gö6976 and scutellarin, FLP-mediated re-expression rescue","journal":"eNeuro","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic models (conventional and conditional KO, re-expression), pharmacological rescue, electrophysiology","pmids":["32033984"],"is_preprint":false},{"year":2020,"finding":"AMPKα1 inhibits PKCγ kinase activity, thereby decreasing phosphorylation and membrane translocation of Hsp90α and suppressing tumor metastasis. Metformin activates AMPKα1 to inhibit PKCγ-mediated Hsp90α secretion.","method":"Mass spectrometry, AMPKα1 overexpression/knockdown, PKCγ kinase activity assay, Hsp90α phosphorylation and secretion assays, in vitro migration/invasion, in vivo metastasis model","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 — kinase activity assay with upstream regulator and downstream phosphorylation; single lab","pmids":["31936169"],"is_preprint":false},{"year":2020,"finding":"PKCγ-mediated phosphorylation of CRMP2 at Thr555 regulates dendritic outgrowth in cerebellar Purkinje cells. Immunoprecipitation-MS identified CRMP2 as a PKCγ(S361G)-interacting protein; Thr555 phosphorylation is increased in PKCγ(S361G) transgenic Purkinje cells. CRMP2 knockdown and Thr555 site mutants reduce dendritic outgrowth; a T555A knock-in mouse shows reduced dendritic development.","method":"Immunoprecipitation-coupled mass spectrometry, Duolink proximity ligation assay, cerebellar slice cultures, miRNA knockdown, phospho-site mutagenesis, T555A knock-in mouse","journal":"Molecular Neurobiology","confidence":"High","confidence_rationale":"Tier 1-2 — MS-identified substrate, confirmed by proximity ligation, phospho-site mutagenesis, and knock-in mouse","pmids":["32860158"],"is_preprint":false},{"year":2021,"finding":"A pseudosubstrate domain knock-in mutation (A24E) in PKCγ causes constitutive activation of the kinase domain while also promoting dephosphorylation and protein degradation, resulting in dramatically reduced PKCγ protein levels but increased PKC activity. Purkinje cells show short thickened dendrites typical of PKC activation, and mice develop marked ataxia.","method":"Knock-in mouse model, PKCγ expression measurement by Western blot, PKC activity assay in Purkinje cells, dendritic morphology analysis, behavioral ataxia testing, RNA profiling","journal":"The Journal of Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — knock-in genetic model with kinase activity measurement and morphological/behavioral readouts","pmids":["33478986"],"is_preprint":false},{"year":2024,"finding":"TRPM2 directly associates with PKCγ via the C2 domain of PKCγ binding to the M2PBM motif on TRPM2. TRPM2-mediated Ca2+ influx promotes PKCγ activation, which subsequently enhances TRPM2-induced potentiation of extrasynaptic NMDAR activity, amplifying excitotoxic neuronal death. Disrupting this interaction with a TAT-M2PBM interfering peptide reduces excitotoxicity and ischemic brain injury.","method":"Identification of interaction motif, co-immunoprecipitation, interfering peptide (TAT-M2PBM), M2PBM deletion constructs, extrasynaptic NMDAR electrophysiology, ischemic stroke models","journal":"Cell Reports","confidence":"High","confidence_rationale":"Tier 1-2 — interaction domain mapped, co-IP validated, interfering peptide with functional and in vivo rescue","pmids":["38308841"],"is_preprint":false},{"year":2013,"finding":"SCA14 mutation V138E in PKCγ C1B domain causes partial unfolding of the protein with exposed C-terminus (shown by FRET-FLIM), faster phorbol ester-induced membrane translocation, and accumulation of fully phosphorylated PKCγ in the insoluble fraction. Co-expression of PDK1 (which triggers PKCγ autophosphorylation) rescues the PKCγ-V138E insolubilization phenotype.","method":"FRET-fluorescence lifetime imaging microscopy (FRET-FLIM) in living cells, phorbol ester-induced translocation assay, phosphorylation state analysis, PDK1 co-expression rescue","journal":"Journal of Neurochemistry","confidence":"High","confidence_rationale":"Tier 1-2 — FRET-FLIM structural evidence plus functional rescue by PDK1; multiple methods","pmids":["24134140"],"is_preprint":false},{"year":2007,"finding":"Glycine inhibitory dysfunction activates a local circuit involving PKCγ-expressing interneurons in the superficial dorsal horn to convert touch into pain. Selective inhibition of PKCγ as well as selective blockade of NMDA receptors in the superficial dorsal horn prevented activation of this circuit and allodynia, establishing PKCγ as required for NMDA-receptor-dependent gating of tactile input to nociceptive neurons.","method":"In vivo electrophysiology, segmental glycine inhibition removal (strychnine), anatomical circuit tracing, pharmacological PKCγ inhibition, NMDA receptor antagonism","journal":"PLoS ONE","confidence":"Medium","confidence_rationale":"Tier 2 — electrophysiology with pharmacological epistasis; single lab","pmids":["17987109"],"is_preprint":false}],"current_model":"PKCγ (PRKCG) is a calcium- and DAG-dependent serine/threonine kinase that, upon activation, translocates to membranes where it phosphorylates diverse substrates including connexins (Cx43, Cx50), syndecan-2, CRMP2, βPIX, and the mu-opioid receptor; it is regulated by 14-3-3ε (inhibitory), DGKγ (limiting DAG availability), Hsp70 (chaperone), and AMPKα1 (inhibitory kinase), and operates in multiple signaling axes including Src-PLD1-PKCγ-cPLA2 in angiogenesis, NMDAR/nNOS/zinc-HINT1 at opioid receptors, and GSK3β/β-catenin in axonal growth; in the spinal cord, PKCγ interneurons are activated by myelinated low-threshold afferents and gate tactile input to nociceptive circuits underlying mechanical allodynia, while in cerebellar Purkinje cells PKCγ regulates climbing fiber synapse pruning, LTD, and dendritic development, and SCA14-causing mutations in the C1 domain cause PKCγ misfolding, amyloid-like aggregation, hyper-activation or loss of function, and Purkinje cell degeneration."},"narrative":{"teleology":[{"year":1997,"claim":"The question of whether PKCγ is required for pain sensation was resolved: PKCγ-null mice retained normal acute nociception but completely failed to develop neuropathic pain, establishing PKCγ as selectively required for injury-induced pain sensitization rather than baseline pain processing.","evidence":"PKCγ knockout mouse with behavioral pain testing across multiple paradigms","pmids":["9323205"],"confidence":"High","gaps":["Downstream substrates mediating the pain-gating function were unknown","The circuit position of PKCγ interneurons relative to afferent types was not determined","Mechanism of transition from acute to persistent hyperexcitability was unclear"]},{"year":2001,"claim":"PKCγ was shown to mediate the transition from short-lived to persistent spinal hyperexcitability via NMDA-dependent circuits, explaining why neuropathic pain requires PKCγ while acute pain does not.","evidence":"Electrophysiology of wide dynamic range neurons in PKCγ-null versus wild-type mice with NMDA antagonist epistasis","pmids":["11438608"],"confidence":"High","gaps":["Identity of the afferent inputs activating PKCγ interneurons was unresolved","Direct phosphorylation substrates in the spinal pain circuit were unknown"]},{"year":2002,"claim":"PKCγ was demonstrated to function outside the nervous system as a direct kinase for syndecan-2, establishing asymmetric phosphorylation as a mechanism for left-right axis determination during Xenopus gastrulation.","evidence":"In vivo phosphorylation assays with dominant-negative and constitutively active PKCγ constructs in Xenopus ectodermal cells","pmids":["12507425"],"confidence":"High","gaps":["Whether this developmental role is conserved in mammals was not tested","The upstream signal generating asymmetric PKCγ activation was not identified"]},{"year":2003,"claim":"PKCγ was identified as the kinase responsible for connexin phosphorylation and gap junction regulation in lens cells, revealing a DAG-dependent (calcium-independent) activation mode downstream of IGF-I signaling.","evidence":"Co-immunoprecipitation, in vitro kinase assay, and scrape-loading dye-transfer in lens epithelial cells","pmids":["12601045"],"confidence":"High","gaps":["Specific phosphorylation sites on Cx43 were not mapped","Whether other connexins (Cx50, Cx46) were similarly regulated was not yet tested"]},{"year":2004,"claim":"14-3-3ε was established as an endogenous inhibitor that sequesters PKCγ via its C1B domain, and competitive release of PKCγ from 14-3-3ε was shown to trigger membrane translocation, Cx43 phosphorylation, and gap junction closure, revealing a discrete regulatory mechanism controlling PKCγ activation state.","evidence":"Synthetic peptide competition binding assays, co-IP, MALDI-TOF MS for binding sites, and functional gap junction assays","pmids":["15459208"],"confidence":"High","gaps":["In vivo relevance of 14-3-3ε regulation of PKCγ was not demonstrated","Whether 14-3-3ε regulates PKCγ in neurons was unknown"]},{"year":2005,"claim":"The first SCA14 mutations in PKCγ were functionally characterized: the H101Q mutation reduced PKCγ protein stability and the S119P mutation caused aggregation in Purkinje cells with dominant-negative effects on wild-type PKCγ, LTD blockade, and impaired climbing fiber synapse pruning, linking PKCγ misfolding to cerebellar degeneration.","evidence":"HEK293 transfection (H101Q), lentiviral expression in mouse Purkinje cells in vivo (S119P) with electrophysiology and morphological analysis","pmids":["16189624","21976518"],"confidence":"High","gaps":["Whether aggregation or loss of kinase function was the primary pathogenic driver was unresolved","In vitro reconstitution of aggregation had not been achieved"]},{"year":2007,"claim":"A spinal circuit mechanism was elucidated: disinhibition (loss of glycinergic tone) activates PKCγ interneurons to gate touch into the nociceptive pathway via NMDA receptor-dependent signaling, establishing PKCγ as the molecular switch for mechanical allodynia.","evidence":"In vivo electrophysiology with strychnine disinhibition, pharmacological PKCγ inhibition, and NMDA antagonism","pmids":["17987109"],"confidence":"Medium","gaps":["The specific afferent fiber type driving PKCγ interneurons was not yet anatomically defined","Downstream targets of PKCγ in this circuit were not identified"]},{"year":2008,"claim":"The afferent input to PKCγ interneurons was anatomically resolved: VGLUT1-positive myelinated low-threshold mechanoreceptors (not unmyelinated nociceptors) synapse directly onto PKCγ interneurons, explaining how touch signals access pain circuits after disinhibition. Separately, PKCγ was recruited to the mu-opioid receptor via HINT1/zinc-dependent scaffolding to phosphorylate MOR and attenuate opioid signaling.","evidence":"Electron microscopic double labeling and VGLUT1 immunohistochemistry (afferent identity); co-IP with HINT1 knockdown and zinc chelation (MOR pathway)","pmids":["18685019","18652891"],"confidence":"High","gaps":["Whether PKCγ phosphorylation of MOR is direct was not shown by in vitro kinase assay","The full circuit downstream of PKCγ interneurons to projection neurons was not mapped"]},{"year":2010,"claim":"PKCγ was positioned within the Src→PLD1→PKCγ→cPLA2 signaling axis driving VEGF-induced retinal angiogenesis, demonstrating a non-neuronal role in endothelial cell migration, proliferation, and neovascularization, while SCA14 mutant PKCγ was shown to be selectively cleared by autophagy.","evidence":"Multiple inhibition strategies (siRNA, dominant-negative, pharmacological) with in vitro and in vivo retinal models; Atg5-KO fibroblasts for autophagy dependence","pmids":["20421451","21536681","20398063"],"confidence":"High","gaps":["Direct PKCγ phosphorylation of cPLA2 was not demonstrated by in vitro kinase assay","Whether autophagy clearance of mutant PKCγ is sufficient to prevent neurodegeneration in vivo was untested"]},{"year":2013,"claim":"FRET-FLIM revealed that SCA14 C1B domain mutations cause partial unfolding of PKCγ with an exposed C-terminus, accelerated membrane translocation, and accumulation of fully phosphorylated protein in the insoluble fraction, providing a structural basis for how point mutations drive both hyperactivation and aggregation.","evidence":"FRET-fluorescence lifetime imaging in living cells with PDK1 co-expression rescue of insolubilization","pmids":["24134140"],"confidence":"High","gaps":["High-resolution structural data for the misfolded state was lacking","Whether PDK1 rescue is therapeutically exploitable was unknown"]},{"year":2014,"claim":"PKCγ was identified as a direct kinase for βPIX at Ser583, linking PKCγ to Ca²⁺-evoked dopamine release in the striatum; PKCγ-null mice develop parkinsonian syndrome, broadening PKCγ's neurological roles beyond pain and cerebellar function. PKCγ amyloid-like fibril formation was reconstituted in vitro from the C1A and kinase domains, with SCA14 mutations accelerating fibrillization.","evidence":"In vitro kinase assay with phospho-site mutagenesis and rescue in PKCγ-KO mice; cell-free fibril formation assay with domain deletion mapping","pmids":["25009260","25217572"],"confidence":"High","gaps":["Whether βPIX phosphorylation is the sole mechanism for dopamine release regulation was not tested","The amyloid fibril structure was not resolved at atomic level"]},{"year":2016,"claim":"A sequential kinase cascade (Hck→PKCδ→PKCγ) was defined for lysoPC-mediated neutrophil priming, with PKCγ phosphorylating p47phox to enable NADPH oxidase activation, establishing PKCγ as an effector in innate immune priming.","evidence":"FRET-confirmed PKCδ–PKCγ interaction, phospho-site identification, PKCγ-KO PMNs, in vivo TRALI model","pmids":["27531930"],"confidence":"High","gaps":["Whether PKCγ directly phosphorylates p47phox was not shown by in vitro kinase assay","Relevance to human neutrophil biology was not confirmed"]},{"year":2018,"claim":"Analysis of patient-derived iPSCs and post-mortem SCA14 cerebellum confirmed that C1 domain mutations cause both gain-of-function (hyperphosphorylation of substrates) and loss-of-function (aggregation/mislocalization) in human tissue, while Hsp70 was identified as a chaperone that binds PKCγ's kinase and C2 domains and can be pharmacologically upregulated to attenuate aggregation and apoptosis.","evidence":"Patient iPSCs, post-mortem immunohistochemistry, substrate phosphorylation assays; co-IP domain mapping, celastrol/herbimycin A rescue in primary Purkinje cells","pmids":["30249303","30093405"],"confidence":"High","gaps":["Whether Hsp70 upregulation is neuroprotective in vivo in SCA14 models was not shown","The relative contribution of gain- versus loss-of-function to disease progression remained unquantified"]},{"year":2020,"claim":"DGKγ was established as a direct negative regulator of PKCγ in Purkinje cells by metabolizing DAG to phosphatidic acid; DGKγ-KO mice phenocopy PKCγ hyperactivation with impaired LTD and dendritic retraction, rescued by PKCγ-specific inhibition. CRMP2 was identified by IP-MS as a direct PKCγ substrate phosphorylated at Thr555 to regulate Purkinje cell dendritic outgrowth, confirmed by a T555A knock-in mouse.","evidence":"Conditional DGKγ KO with pharmacological rescue; IP-MS substrate identification, proximity ligation, phospho-site mutagenesis, T555A knock-in mouse","pmids":["32033984","32860158"],"confidence":"High","gaps":["Additional PKCγ substrates in Purkinje cells likely remain unidentified","How CRMP2 phosphorylation interacts with other PKCγ-dependent dendritic signals was not tested"]},{"year":2021,"claim":"A pseudosubstrate domain knock-in (A24E) proved that constitutive PKCγ kinase activation paradoxically leads to protein degradation and reduced steady-state levels while still driving aberrant Purkinje cell morphology and ataxia, clarifying that even transient hyperactivation is pathogenic.","evidence":"A24E knock-in mouse with PKC activity measurement, dendritic morphology, and behavioral analysis","pmids":["33478986"],"confidence":"High","gaps":["The degradation pathway (proteasomal vs. autophagic) for constitutively active PKCγ was not defined","Whether pharmacological dampening of PKCγ activity could rescue the A24E phenotype was not tested"]},{"year":2024,"claim":"TRPM2 was identified as a direct PKCγ-interacting partner via the C2 domain–M2PBM interface, establishing a feedforward loop: TRPM2-mediated Ca²⁺ influx activates PKCγ, which then potentiates extrasynaptic NMDAR activity to amplify excitotoxicity. An interfering peptide disrupting this interaction was neuroprotective in ischemic stroke models.","evidence":"Interaction motif mapping, co-IP, TAT-M2PBM interfering peptide, extrasynaptic NMDAR electrophysiology, ischemic stroke models in vivo","pmids":["38308841"],"confidence":"High","gaps":["Whether PKCγ directly phosphorylates TRPM2 or NMDARs was not determined","Long-term efficacy and specificity of TAT-M2PBM in vivo were not assessed"]},{"year":null,"claim":"Key unresolved questions include: the full repertoire of PKCγ substrates in spinal dorsal horn pain circuits, the atomic-resolution structure of PKCγ and its SCA14 aggregates, the relative therapeutic value of targeting gain-of-function versus loss-of-function mechanisms in SCA14, and how PKCγ signaling is coordinated across its diverse neuronal and non-neuronal contexts.","evidence":"","pmids":[],"confidence":"Low","gaps":["No substrate identified in spinal PKCγ interneurons","No high-resolution structure of full-length PKCγ or its amyloid fibrils","No clinical trial data for PKCγ-targeted therapies in SCA14 or neuropathic pain"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[2,3,5,17,27,29]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[3,4,5]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,5,18,29]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[4,21,30]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,8,10,14,15,20,23,29]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,1,7,9,29,31]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[6,11,19,21,28,30]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,25,27]}],"complexes":[],"partners":["YWHAE","HINT1","DGKG","DPYSL2","ARHGEF7","TRPM2","HSPA1A","GJA1"],"other_free_text":[]},"mechanistic_narrative":"PKCγ (PRKCG) is a calcium- and diacylglycerol-dependent serine/threonine kinase that functions as a critical signaling node in neuronal circuit development, synaptic plasticity, pain processing, and diverse non-neuronal signaling pathways. In cerebellar Purkinje cells, PKCγ phosphorylates CRMP2 at Thr555 to regulate dendritic outgrowth, controls climbing fiber synapse pruning and long-term depression (LTD), and is negatively regulated by DGKγ-mediated DAG consumption, 14-3-3ε binding to its C1B domain, and AMPK α1-mediated inhibition [PMID:32860158, PMID:32033984, PMID:15459208, PMID:31936169]. In the spinal dorsal horn, PKCγ-expressing interneurons receive myelinated low-threshold mechanoreceptor input and gate tactile signals into nociceptive circuits; PKCγ-null mice lack neuropathic pain and fail to sustain NMDA-dependent hyperexcitability after tissue injury [PMID:9323205, PMID:18685019, PMID:11438608]. Missense mutations in the C1 domain of PRKCG cause spinocerebellar ataxia type 14 (SCA14), in which PKCγ undergoes misfolding, amyloid-like aggregation, and combined gain- and loss-of-function that drives Purkinje cell degeneration [PMID:25217572, PMID:30249303, PMID:21976518]."},"prefetch_data":{"uniprot":{"accession":"P05129","full_name":"Protein kinase C gamma type","aliases":[],"length_aa":697,"mass_kda":78.4,"function":"Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays diverse roles in neuronal cells and eye tissues, such as regulation of the neuronal receptors GRIA4/GLUR4 and GRIN1/NMDAR1, modulation of receptors and neuronal functions related to sensitivity to opiates, pain and alcohol, mediation of synaptic function and cell survival after ischemia, and inhibition of gap junction activity after oxidative stress. Binds and phosphorylates GRIA4/GLUR4 glutamate receptor and regulates its function by increasing plasma membrane-associated GRIA4 expression. In primary cerebellar neurons treated with the agonist 3,5-dihyidroxyphenylglycine, functions downstream of the metabotropic glutamate receptor GRM5/MGLUR5 and phosphorylates GRIN1/NMDAR1 receptor which plays a key role in synaptic plasticity, synaptogenesis, excitotoxicity, memory acquisition and learning. May be involved in the regulation of hippocampal long-term potentiation (LTP), but may be not necessary for the process of synaptic plasticity. May be involved in desensitization of mu-type opioid receptor-mediated G-protein activation in the spinal cord, and may be critical for the development and/or maintenance of morphine-induced reinforcing effects in the limbic forebrain. May modulate the functionality of mu-type-opioid receptors by participating in a signaling pathway which leads to the phosphorylation and degradation of opioid receptors. May also contributes to chronic morphine-induced changes in nociceptive processing. Plays a role in neuropathic pain mechanisms and contributes to the maintenance of the allodynia pain produced by peripheral inflammation. Plays an important role in initial sensitivity and tolerance to ethanol, by mediating the behavioral effects of ethanol as well as the effects of this drug on the GABA(A) receptors. During and after cerebral ischemia modulate neurotransmission and cell survival in synaptic membranes, and is involved in insulin-induced inhibition of necrosis, an important mechanism for minimizing ischemic injury. Required for the elimination of multiple climbing fibers during innervation of Purkinje cells in developing cerebellum. Is activated in lens epithelial cells upon hydrogen peroxide treatment, and phosphorylates connexin-43 (GJA1/CX43), resulting in disassembly of GJA1 gap junction plaques and inhibition of gap junction activity which could provide a protective effect against oxidative stress (By similarity). Phosphorylates p53/TP53 and promotes p53/TP53-dependent apoptosis in response to DNA damage. Involved in the phase resetting of the cerebral cortex circadian clock during temporally restricted feeding. Stabilizes the core clock component BMAL1 by interfering with its ubiquitination, thus suppressing its degradation, resulting in phase resetting of the cerebral cortex clock (By similarity). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231)","subcellular_location":"Cytoplasm; Cytoplasm, perinuclear region; Cell membrane; Synapse, synaptosome; Cell projection, dendrite","url":"https://www.uniprot.org/uniprotkb/P05129/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PRKCG","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PRKCG","total_profiled":1310},"omim":[{"mim_id":"618093","title":"SPINOCEREBELLAR ATAXIA 48; SCA48","url":"https://www.omim.org/entry/618093"},{"mim_id":"608317","title":"GRAINYHEAD-LIKE 3; GRHL3","url":"https://www.omim.org/entry/608317"},{"mim_id":"607207","title":"STIP1 HOMOLOGOUS AND U BOX-CONTAINING PROTEIN 1; STUB1","url":"https://www.omim.org/entry/607207"},{"mim_id":"607172","title":"SERINE/THREONINE KINASE 11-INTERACTING PROTEIN; STK11IP","url":"https://www.omim.org/entry/607172"},{"mim_id":"606900","title":"CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-8 SUBUNIT; CACNG8","url":"https://www.omim.org/entry/606900"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":50.1}],"url":"https://www.proteinatlas.org/search/PRKCG"},"hgnc":{"alias_symbol":["PKCC","MGC57564","PKCγ"],"prev_symbol":["PKCG","SCA14"]},"alphafold":{"accession":"P05129","domains":[{"cath_id":"3.30.60.20","chopping":"25-90_98-155","consensus_level":"medium","plddt":86.6525,"start":25,"end":155},{"cath_id":"2.60.40.150","chopping":"161-293","consensus_level":"high","plddt":93.3208,"start":161,"end":293},{"cath_id":"3.30.200.20","chopping":"349-439_636-682","consensus_level":"medium","plddt":84.7136,"start":349,"end":682},{"cath_id":"1.10.510.10","chopping":"442-635","consensus_level":"medium","plddt":93.1559,"start":442,"end":635}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P05129","model_url":"https://alphafold.ebi.ac.uk/files/AF-P05129-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P05129-F1-predicted_aligned_error_v6.png","plddt_mean":81.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PRKCG","jax_strain_url":"https://www.jax.org/strain/search?query=PRKCG"},"sequence":{"accession":"P05129","fasta_url":"https://rest.uniprot.org/uniprotkb/P05129.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P05129/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P05129"}},"corpus_meta":[{"pmid":"9323205","id":"PMC_9323205","title":"Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma.","date":"1997","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9323205","citation_count":546,"is_preprint":false},{"pmid":"17987109","id":"PMC_17987109","title":"Glycine inhibitory dysfunction turns touch into pain through PKCgamma interneurons.","date":"2007","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/17987109","citation_count":150,"is_preprint":false},{"pmid":"18685019","id":"PMC_18685019","title":"Innocuous, not noxious, input activates PKCgamma interneurons of the spinal dorsal horn via myelinated afferent fibers.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18685019","citation_count":143,"is_preprint":false},{"pmid":"22985497","id":"PMC_22985497","title":"Ketamine potentiates hippocampal neurodegeneration and persistent learning and memory impairment through the PKCγ-ERK signaling pathway in the developing brain.","date":"2012","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/22985497","citation_count":91,"is_preprint":false},{"pmid":"10939565","id":"PMC_10939565","title":"A novel locus for dominant cerebellar ataxia (SCA14) maps to a 10.2-cM interval flanked by D19S206 and D19S605 on chromosome 19q13.4-qter.","date":"2000","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/10939565","citation_count":90,"is_preprint":false},{"pmid":"11438608","id":"PMC_11438608","title":"PKCgamma contributes to a subset of the NMDA-dependent spinal circuits that underlie injury-induced persistent pain.","date":"2001","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11438608","citation_count":85,"is_preprint":false},{"pmid":"12507425","id":"PMC_12507425","title":"PKCgamma regulates syndecan-2 inside-out signaling during xenopus left-right development.","date":"2002","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/12507425","citation_count":85,"is_preprint":false},{"pmid":"16319314","id":"PMC_16319314","title":"Expression of spinal NMDA receptor and PKCgamma after chronic morphine is regulated by spinal glucocorticoid receptor.","date":"2005","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16319314","citation_count":81,"is_preprint":false},{"pmid":"14694043","id":"PMC_14694043","title":"Identification of a novel SCA14 mutation in a Dutch autosomal dominant cerebellar ataxia family.","date":"2003","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/14694043","citation_count":77,"is_preprint":false},{"pmid":"21976518","id":"PMC_21976518","title":"Mutant PKCγ in spinocerebellar ataxia type 14 disrupts synapse elimination and long-term depression in Purkinje cells in vivo.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21976518","citation_count":67,"is_preprint":false},{"pmid":"12505882","id":"PMC_12505882","title":"Dopaminergic inhibition of secretin-stimulated choleresis by increased PKC-gamma expression and decrease of PKA activity.","date":"2002","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12505882","citation_count":56,"is_preprint":false},{"pmid":"18652891","id":"PMC_18652891","title":"NMDAR-nNOS generated zinc recruits PKCgamma to the HINT1-RGS17 complex bound to the C terminus of Mu-opioid receptors.","date":"2008","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/18652891","citation_count":53,"is_preprint":false},{"pmid":"12000125","id":"PMC_12000125","title":"Individual differences in spatial memory among aged rats are related to hippocampal PKCgamma immunoreactivity.","date":"2002","source":"Hippocampus","url":"https://pubmed.ncbi.nlm.nih.gov/12000125","citation_count":53,"is_preprint":false},{"pmid":"12601045","id":"PMC_12601045","title":"IGF-I-induced phosphorylation of connexin 43 by PKCgamma: regulation of gap junctions in rabbit lens epithelial cells.","date":"2003","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/12601045","citation_count":50,"is_preprint":false},{"pmid":"30355630","id":"PMC_30355630","title":"5-HT2A Receptor-Induced Morphological Reorganization of PKCγ-Expressing Interneurons Gates Inflammatory Mechanical Allodynia in Rat.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30355630","citation_count":47,"is_preprint":false},{"pmid":"12438709","id":"PMC_12438709","title":"Search for the second Peutz-Jeghers syndrome locus: exclusion of the STK13, PRKCG, KLK10, and PSCD2 genes on chromosome 19 and the STK11IP gene on chromosome 2.","date":"2002","source":"Cytogenetic and genome research","url":"https://pubmed.ncbi.nlm.nih.gov/12438709","citation_count":45,"is_preprint":false},{"pmid":"30249303","id":"PMC_30249303","title":"Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation.","date":"2018","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/30249303","citation_count":42,"is_preprint":false},{"pmid":"21155805","id":"PMC_21155805","title":"PKCγ is required for ethanol-induced increases in GABA(A) receptor α4 subunit expression in cultured cerebral cortical neurons.","date":"2011","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21155805","citation_count":42,"is_preprint":false},{"pmid":"16547918","id":"PMC_16547918","title":"Novel PRKCG/SCA14 mutation in a Dutch spinocerebellar ataxia family: expanding the phenotype.","date":"2006","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/16547918","citation_count":39,"is_preprint":false},{"pmid":"28338001","id":"PMC_28338001","title":"Renin-angiotensin system acting on reactive oxygen species in paraventricular nucleus induces sympathetic activation via AT1R/PKCγ/Rac1 pathway in salt-induced hypertension.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28338001","citation_count":39,"is_preprint":false},{"pmid":"21087146","id":"PMC_21087146","title":"Intrathecal lentiviral-mediated RNA interference targeting PKCγ attenuates chronic constriction injury-induced neuropathic pain in rats.","date":"2011","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/21087146","citation_count":36,"is_preprint":false},{"pmid":"20421451","id":"PMC_20421451","title":"PLD1-dependent PKCgamma activation downstream to Src is essential for the development of pathologic retinal neovascularization.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20421451","citation_count":35,"is_preprint":false},{"pmid":"16123426","id":"PMC_16123426","title":"Regulation of lens cell-to-cell communication by activation of PKCgamma and disassembly of Cx50 channels.","date":"2005","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/16123426","citation_count":34,"is_preprint":false},{"pmid":"23319572","id":"PMC_23319572","title":"Both Kdr and Flt1 play a vital role in hypoxia-induced Src-PLD1-PKCγ-cPLA(2) activation and retinal neovascularization.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23319572","citation_count":34,"is_preprint":false},{"pmid":"21781114","id":"PMC_21781114","title":"L-type voltage-dependent calcium channels facilitate acetylation of histone H3 through PKCγ phosphorylation in mice with methamphetamine-induced place preference.","date":"2011","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21781114","citation_count":31,"is_preprint":false},{"pmid":"22675081","id":"PMC_22675081","title":"Exome sequencing in an SCA14 family demonstrates its utility in diagnosing heterogeneous diseases.","date":"2012","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22675081","citation_count":30,"is_preprint":false},{"pmid":"16189624","id":"PMC_16189624","title":"A novel H101Q mutation causes PKCgamma loss in spinocerebellar ataxia type 14.","date":"2005","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16189624","citation_count":30,"is_preprint":false},{"pmid":"15459208","id":"PMC_15459208","title":"Inhibition of gap junction activity through the release of the C1B domain of protein kinase Cgamma (PKCgamma) from 14-3-3: identification of PKCgamma-binding sites.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15459208","citation_count":30,"is_preprint":false},{"pmid":"21235400","id":"PMC_21235400","title":"NO-released zinc supports the simultaneous binding of Raf-1 and PKCγ cysteine-rich domains to HINT1 protein at the mu-opioid receptor.","date":"2011","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21235400","citation_count":29,"is_preprint":false},{"pmid":"12524182","id":"PMC_12524182","title":"Alterations in PKCgamma in the mouse hippocampus after prenatal exposure to heroin: a link from cell signaling to behavioral outcome.","date":"2003","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/12524182","citation_count":29,"is_preprint":false},{"pmid":"17883942","id":"PMC_17883942","title":"Effects of scutellarin on PKCgamma in PC12 cell injury induced by oxygen and glucose deprivation.","date":"2007","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/17883942","citation_count":28,"is_preprint":false},{"pmid":"19366675","id":"PMC_19366675","title":"PKCgamma-induced trafficking of AMPA receptors in embryonic zebrafish depends on NSF and PICK1.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19366675","citation_count":28,"is_preprint":false},{"pmid":"23185022","id":"PMC_23185022","title":"PKCγ participates in food entrainment by regulating BMAL1.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23185022","citation_count":28,"is_preprint":false},{"pmid":"16763984","id":"PMC_16763984","title":"Identification of a new family of spinocerebellar ataxia type 14 in the Japanese spinocerebellar ataxia population by the screening of PRKCG exon 4.","date":"2006","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/16763984","citation_count":27,"is_preprint":false},{"pmid":"15841389","id":"PMC_15841389","title":"Gly118Asp is a SCA14 founder mutation in the Dutch ataxia population.","date":"2005","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15841389","citation_count":26,"is_preprint":false},{"pmid":"21393551","id":"PMC_21393551","title":"PKCgamma in Vc and C1/C2 is involved in trigeminal neuropathic pain.","date":"2011","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/21393551","citation_count":26,"is_preprint":false},{"pmid":"25961142","id":"PMC_25961142","title":"Subpopulations of PKCγ interneurons within the medullary dorsal horn revealed by electrophysiologic and morphologic approach.","date":"2015","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/25961142","citation_count":26,"is_preprint":false},{"pmid":"24899266","id":"PMC_24899266","title":"PLCγ1-PKCγ signaling-mediated Hsp90α plasma membrane translocation facilitates tumor metastasis.","date":"2014","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/24899266","citation_count":26,"is_preprint":false},{"pmid":"20362561","id":"PMC_20362561","title":"Involvement of the spinal NMDA receptor/PKCγ signaling pathway in the development of bone cancer pain.","date":"2010","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/20362561","citation_count":25,"is_preprint":false},{"pmid":"22309983","id":"PMC_22309983","title":"Amitriptyline attenuates astrocyte activation and morphine tolerance in rats: role of the PSD-95/NR1/nNOS/PKCγ signaling pathway.","date":"2012","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/22309983","citation_count":25,"is_preprint":false},{"pmid":"22284620","id":"PMC_22284620","title":"Identification of differentially expressed proteins in the spinal cord of neuropathic pain models with PKCgamma silence by proteomic analysis.","date":"2012","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/22284620","citation_count":25,"is_preprint":false},{"pmid":"26399641","id":"PMC_26399641","title":"Carbonic Anhydrase 8 Expression in Purkinje Cells Is Controlled by PKCγ Activity and Regulates Purkinje Cell Dendritic Growth.","date":"2015","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/26399641","citation_count":24,"is_preprint":false},{"pmid":"23769718","id":"PMC_23769718","title":"Transient, 5-HT2B receptor-mediated facilitation in neuropathic pain: Up-regulation of PKCγ and engagement of the NMDA receptor in dorsal horn neurons.","date":"2013","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/23769718","citation_count":24,"is_preprint":false},{"pmid":"15585346","id":"PMC_15585346","title":"Spatial memory in aged rats is related to PKCgamma-dependent G-protein coupling of the M1 receptor.","date":"2005","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/15585346","citation_count":24,"is_preprint":false},{"pmid":"15196660","id":"PMC_15196660","title":"Prenatal heroin exposure alters cholinergic receptor stimulated activation of the PKCbetaII and PKCgamma isoforms.","date":"2004","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/15196660","citation_count":23,"is_preprint":false},{"pmid":"18706478","id":"PMC_18706478","title":"Inhibition of PKCgamma membrane translocation mediated morphine preconditioning-induced neuroprotection against oxygen-glucose deprivation in the hippocampus slices of mice.","date":"2008","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/18706478","citation_count":23,"is_preprint":false},{"pmid":"11420074","id":"PMC_11420074","title":"Differential sensitivity to the anxiolytic effects of ethanol and flunitrazepam in PKCgamma null mutant mice.","date":"2001","source":"Pharmacology, biochemistry, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/11420074","citation_count":22,"is_preprint":false},{"pmid":"26318332","id":"PMC_26318332","title":"EphrinB-EphB signaling regulates spinal pain processing via PKCγ.","date":"2015","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26318332","citation_count":22,"is_preprint":false},{"pmid":"25217572","id":"PMC_25217572","title":"Identification and characterization of PKCγ, a kinase associated with SCA14, as an amyloidogenic protein.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25217572","citation_count":21,"is_preprint":false},{"pmid":"16291902","id":"PMC_16291902","title":"Spinocerebellar ataxia type 14: study of a family with an exon 5 mutation in the PRKCG gene.","date":"2005","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16291902","citation_count":21,"is_preprint":false},{"pmid":"20398063","id":"PMC_20398063","title":"Mutant protein kinase C gamma that causes spinocerebellar ataxia type 14 (SCA14) is selectively degraded by autophagy.","date":"2010","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/20398063","citation_count":20,"is_preprint":false},{"pmid":"27848062","id":"PMC_27848062","title":"Involvement of Spinal CCR5/PKCγ Signaling Pathway in the Maintenance of Cancer-Induced Bone Pain.","date":"2016","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/27848062","citation_count":20,"is_preprint":false},{"pmid":"10499359","id":"PMC_10499359","title":"Chronic exposure to lead acetate affects the development of protein kinase C activity and the distribution of the PKCgamma isozyme in the rat hippocampus.","date":"1999","source":"Neurotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/10499359","citation_count":20,"is_preprint":false},{"pmid":"21536681","id":"PMC_21536681","title":"Activation of cytosolic phospholipase A2 downstream of the Src-phospholipase D1 (PLD1)-protein kinase C γ (PKCγ) signaling axis is required for hypoxia-induced pathological retinal angiogenesis.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21536681","citation_count":20,"is_preprint":false},{"pmid":"24890317","id":"PMC_24890317","title":"Mechanism of GABA involvement in post-traumatic trigeminal neuropathic pain: activation of neuronal circuitry composed of PKCγ interneurons and pERK1/2 expressing neurons.","date":"2014","source":"European journal of pain (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24890317","citation_count":20,"is_preprint":false},{"pmid":"34462460","id":"PMC_34462460","title":"Protocatechuic acid attenuates isoproterenol-induced cardiac hypertrophy via downregulation of ROCK1-Sp1-PKCγ axis.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34462460","citation_count":20,"is_preprint":false},{"pmid":"23837410","id":"PMC_23837410","title":"PKCγ receptor mediates visceral nociception and hyperalgesia following exposure to PTSD-like stress in the spinal cord of rats.","date":"2013","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/23837410","citation_count":19,"is_preprint":false},{"pmid":"23385082","id":"PMC_23385082","title":"Protein kinase C gamma (PKCγ) as a novel marker to assess the functional status of the corticospinal tract in experimental autoimmune encephalomyelitis (EAE).","date":"2013","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/23385082","citation_count":19,"is_preprint":false},{"pmid":"32108249","id":"PMC_32108249","title":"PKCγ interneurons, a gateway to pathological pain in the dorsal horn.","date":"2020","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/32108249","citation_count":18,"is_preprint":false},{"pmid":"31936169","id":"PMC_31936169","title":"Metformin Inhibits Tumor Metastasis through Suppressing Hsp90α Secretion in an AMPKα1-PKCγ Dependent Manner.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/31936169","citation_count":18,"is_preprint":false},{"pmid":"18986758","id":"PMC_18986758","title":"Expansion of the phenotypic spectrum of SCA14 caused by the Gly128Asp mutation in PRKCG.","date":"2008","source":"Clinical neurology and neurosurgery","url":"https://pubmed.ncbi.nlm.nih.gov/18986758","citation_count":17,"is_preprint":false},{"pmid":"32033984","id":"PMC_32033984","title":"DGKγ Knock-Out Mice Show Impairments in Cerebellar Motor Coordination, LTD, and the Dendritic Development of Purkinje Cells through the Activation of PKCγ.","date":"2020","source":"eNeuro","url":"https://pubmed.ncbi.nlm.nih.gov/32033984","citation_count":17,"is_preprint":false},{"pmid":"17343273","id":"PMC_17343273","title":"PRKCG mutation (SCA-14) causing a Ramsay Hunt phenotype.","date":"2007","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/17343273","citation_count":17,"is_preprint":false},{"pmid":"33478986","id":"PMC_33478986","title":"A New Mouse Model Related to SCA14 Carrying a Pseudosubstrate Domain Mutation in PKCγ Shows Perturbed Purkinje Cell Maturation and Ataxic Motor Behavior.","date":"2021","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33478986","citation_count":16,"is_preprint":false},{"pmid":"31515469","id":"PMC_31515469","title":"ΔNp63α suppresses cells invasion by downregulating PKCγ/Rac1 signaling through miR-320a.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31515469","citation_count":16,"is_preprint":false},{"pmid":"31158466","id":"PMC_31158466","title":"Spinocerebellar ataxia type 14 caused by a nonsense mutation in the PRKCG gene.","date":"2019","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/31158466","citation_count":15,"is_preprint":false},{"pmid":"30093405","id":"PMC_30093405","title":"Pharmacological induction of heat shock proteins ameliorates toxicity of mutant PKCγ in spinocerebellar ataxia type 14.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30093405","citation_count":15,"is_preprint":false},{"pmid":"19056342","id":"PMC_19056342","title":"Loss of Purkinje cells in the PKCgamma H101Y transgenic mouse.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19056342","citation_count":15,"is_preprint":false},{"pmid":"18774262","id":"PMC_18774262","title":"mGluR5-PLCbeta4-PKCbeta2/PKCgamma pathways in hippocampal CA1 pyramidal neurons in pilocarpine model of status epilepticus in mGluR5+/+ mice.","date":"2008","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/18774262","citation_count":15,"is_preprint":false},{"pmid":"17149711","id":"PMC_17149711","title":"Spinocerebellar ataxia 14: novel mutation in exon 2 of PRKCG in a German family.","date":"2007","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/17149711","citation_count":14,"is_preprint":false},{"pmid":"27531930","id":"PMC_27531930","title":"LysoPCs induce Hck- and PKCδ-mediated activation of PKCγ causing p47phox phosphorylation and membrane translocation in neutrophils.","date":"2016","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/27531930","citation_count":14,"is_preprint":false},{"pmid":"21434874","id":"PMC_21434874","title":"SCA14 in Norway, two families with autosomal dominant cerebellar ataxia and a novel mutation in the PRKCG gene.","date":"2011","source":"Acta neurologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/21434874","citation_count":14,"is_preprint":false},{"pmid":"32860158","id":"PMC_32860158","title":"PKCγ-Mediated Phosphorylation of CRMP2 Regulates Dendritic Outgrowth in Cerebellar Purkinje Cells.","date":"2020","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/32860158","citation_count":14,"is_preprint":false},{"pmid":"17050852","id":"PMC_17050852","title":"PKCgamma knockout mouse lenses are more susceptible to oxidative stress damage.","date":"2006","source":"The Journal of experimental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17050852","citation_count":14,"is_preprint":false},{"pmid":"37344815","id":"PMC_37344815","title":"Non-synonymous SNPs variants of PRKCG and its association with oncogenes predispose to hepatocellular carcinoma.","date":"2023","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/37344815","citation_count":13,"is_preprint":false},{"pmid":"17508994","id":"PMC_17508994","title":"The human protein kinase C gamma gene (PRKCG) as a susceptibility locus for behavioral disinhibition.","date":"2007","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/17508994","citation_count":13,"is_preprint":false},{"pmid":"31745212","id":"PMC_31745212","title":"PKCγ promotes axonal remodeling in the cortico-spinal tract via GSK3β/β-catenin signaling after traumatic brain injury.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31745212","citation_count":13,"is_preprint":false},{"pmid":"38308841","id":"PMC_38308841","title":"TRPM2 enhances ischemic excitotoxicity by associating with PKCγ.","date":"2024","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/38308841","citation_count":13,"is_preprint":false},{"pmid":"25252845","id":"PMC_25252845","title":"Single-nucleotide polymorphisms of the PRKCG gene and osteosarcoma susceptibility.","date":"2014","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25252845","citation_count":12,"is_preprint":false},{"pmid":"17024314","id":"PMC_17024314","title":"A Japanese case of SCA14 with the Gly128Asp mutation.","date":"2006","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17024314","citation_count":12,"is_preprint":false},{"pmid":"23055050","id":"PMC_23055050","title":"Inhibition of the PKCγ-ε pathway relieves from meningeal nociception in an animal model: an innovative perspective for migraine therapy?","date":"2013","source":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/23055050","citation_count":12,"is_preprint":false},{"pmid":"25009260","id":"PMC_25009260","title":"The role of Pak-interacting exchange factor-β phosphorylation at serines 340 and 583 by PKCγ in dopamine release.","date":"2014","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25009260","citation_count":12,"is_preprint":false},{"pmid":"22860055","id":"PMC_22860055","title":"Proteomic analysis of PKCγ-related proteins in the spinal cord of morphine-tolerant rats.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22860055","citation_count":12,"is_preprint":false},{"pmid":"25592416","id":"PMC_25592416","title":"Puerarin alleviates noise-induced hearing loss via affecting PKCγ and GABAB receptor expression.","date":"2015","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25592416","citation_count":11,"is_preprint":false},{"pmid":"21599470","id":"PMC_21599470","title":"PKCγ, role in lens differentiation and gap junction coupling.","date":"2011","source":"Current eye research","url":"https://pubmed.ncbi.nlm.nih.gov/21599470","citation_count":10,"is_preprint":false},{"pmid":"36012439","id":"PMC_36012439","title":"The Emerging Key Role of the mGluR1-PKCγ Signaling Pathway in the Pathogenesis of Spinocerebellar Ataxias: A Neurodevelopmental Viewpoint.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36012439","citation_count":10,"is_preprint":false},{"pmid":"34898326","id":"PMC_34898326","title":"The PKCγ neurons in anterior cingulate cortex contribute to the development of neuropathic allodynia and pain-related emotion.","date":"2021","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/34898326","citation_count":10,"is_preprint":false},{"pmid":"25635962","id":"PMC_25635962","title":"PKCγ-positive neurons gate light tactile inputs to pain pathway through pERK1/2 neuronal network in trigeminal neuropathic pain model.","date":"2015","source":"Journal of oral & facial pain and headache","url":"https://pubmed.ncbi.nlm.nih.gov/25635962","citation_count":10,"is_preprint":false},{"pmid":"11436000","id":"PMC_11436000","title":"PKCalpha and PKCgamma overexpression causes lentoid body formation in the N/N 1003A rabbit lens epithelial cell line.","date":"2001","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/11436000","citation_count":10,"is_preprint":false},{"pmid":"25663494","id":"PMC_25663494","title":"Genetic variations in the PRKCG gene and osteosarcoma risk in a Chinese population: a case-control study.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25663494","citation_count":9,"is_preprint":false},{"pmid":"33584249","id":"PMC_33584249","title":"Motor Dyscoordination and Alteration of Functional Correlation Between DGKγ and PKCγ in Senescence-Accelerated Mouse Prone 8 (SAMP8).","date":"2021","source":"Frontiers in aging neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33584249","citation_count":9,"is_preprint":false},{"pmid":"26921055","id":"PMC_26921055","title":"The interaction of combined effects of the BDNF and PRKCG genes and negative life events in major depressive disorder.","date":"2016","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/26921055","citation_count":9,"is_preprint":false},{"pmid":"32487697","id":"PMC_32487697","title":"PDK1 Regulates the Maintenance of Cell Body and the Development of Dendrites of Purkinje Cells by pS6 and PKCγ.","date":"2020","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32487697","citation_count":9,"is_preprint":false},{"pmid":"20938103","id":"PMC_20938103","title":"Congo red, an amyloid-inhibiting compound, alleviates various types of cellular dysfunction triggered by mutant protein kinase cγ that causes spinocerebellar ataxia type 14 (SCA14) by inhibiting oligomerization and aggregation.","date":"2010","source":"Journal of pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/20938103","citation_count":9,"is_preprint":false},{"pmid":"33114041","id":"PMC_33114041","title":"Precise Regulation of the Basal PKCγ Activity by DGKγ Is Crucial for Motor Coordination.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33114041","citation_count":9,"is_preprint":false},{"pmid":"12506405","id":"PMC_12506405","title":"Effects of prenyl pyrophosphates on the binding of PKCgamma with RACK1.","date":"2003","source":"Journal of experimental zoology. Part A, Comparative experimental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12506405","citation_count":9,"is_preprint":false},{"pmid":"19466636","id":"PMC_19466636","title":"Experience on the Barnes spatial maze influences PKCgamma levels in the hippocampus.","date":"2009","source":"The International journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19466636","citation_count":8,"is_preprint":false},{"pmid":"24134140","id":"PMC_24134140","title":"SCA14 mutation V138E leads to partly unfolded PKCγ associated with an exposed C-terminus, altered kinetics, phosphorylation and enhanced insolubilization.","date":"2013","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24134140","citation_count":7,"is_preprint":false},{"pmid":"31870892","id":"PMC_31870892","title":"Upregulation of spinal glucose-dependent insulinotropic polypeptide receptor induces membrane translocation of PKCγ and synaptic target of AMPA receptor GluR1 subunits in dorsal horns in a rat model of incisional pain.","date":"2019","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/31870892","citation_count":7,"is_preprint":false},{"pmid":"36672978","id":"PMC_36672978","title":"Pathogenicity of PKCγ Genetic Variants-Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer.","date":"2023","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36672978","citation_count":7,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52250,"output_tokens":8275,"usd":0.140437},"stage2":{"model":"claude-opus-4-6","input_tokens":12542,"output_tokens":4522,"usd":0.26364},"total_usd":0.404077,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"PKCγ-null mice display normal acute pain responses but fail to develop neuropathic pain after partial sciatic nerve section, establishing PKCγ as required for injury-induced persistent pain sensitization. PKCγ was found restricted to a small subset of dorsal horn interneurons.\",\n      \"method\": \"PKCγ knockout mouse model, behavioral pain testing, neurochemical analysis\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with specific phenotypic readout, replicated across multiple pain paradigms\",\n      \"pmids\": [\"9323205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PKCγ mediates the transition from short-term to long-term hyperexcitability of lamina V nociresponsive neurons after tissue injury (mustard oil). Wild-type mice showed progressive enhancement of wide dynamic range neuron responses while PKCγ-null mice showed hyperexcitability lasting <30 min. PKCγ contributes to a subset of NMDA-dependent spinal circuits underlying persistent pain.\",\n      \"method\": \"Electrophysiological recordings and behavioral assays in PKCγ-null vs wild-type mice, NMDA receptor antagonist pharmacology\",\n      \"journal\": \"The Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal electrophysiology and behavior in KO vs WT, NMDA antagonist epistasis\",\n      \"pmids\": [\"11438608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PKCγ mediates phosphorylation of the cytoplasmic domain of syndecan-2 in right (but not left) ectodermal cells during Xenopus gastrulation, and this asymmetric phosphorylation is required for left-right development via syndecan-2-mediated inside-out signaling to adjacent migrating mesodermal cells.\",\n      \"method\": \"In vivo phosphorylation assays, dominant-negative/constitutively active PKCγ constructs, animal cap ectodermal cell experiments in Xenopus\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct phosphorylation assay with functional rescue/LOF, published in Cell\",\n      \"pmids\": [\"12507425\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"IGF-I activates and translocates PKCγ in lens epithelial cells, leading to coimmunoprecipitation with and phosphorylation of connexin 43 (Cx43), resulting in decreased gap junction activity. IGF-I increases endogenous DAG which triggers PKCγ translocation; calcium mobilization is not essential for this effect.\",\n      \"method\": \"Western blot, co-immunoprecipitation, PKC translocation assay, in vitro PKC phosphorylation assay, scrape-loading/dye-transfer gap junction assay, confocal microscopy\",\n      \"journal\": \"Investigative Ophthalmology & Visual Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro kinase assay, co-IP, and functional gap junction assay in same study\",\n      \"pmids\": [\"12601045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"14-3-3ε binds the C1B domain of PKCγ at two sites (C1B1: residues 101-112 and C1B5: residues 141-151) to inhibit PKCγ activity. Synthetic peptides corresponding to these sites compete for 14-3-3ε binding, releasing PKCγ, causing its phosphorylation and membrane translocation, which leads to Cx43 phosphorylation and inhibition of gap junction activity.\",\n      \"method\": \"In vitro and in vivo competition binding assays with synthetic peptides, co-immunoprecipitation, PKC enzyme activity assay, gap junction dye-transfer assay, HPLC, MALDI-TOF MS\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — peptide competition with binding site identification, in vitro and in vivo, functional assay\",\n      \"pmids\": [\"15459208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Activation of PKCγ by phorbol ester (TPA) in rat lens disassembles Cx50 gap junction channels: PKCγ translocates to membrane fractions containing Cx46, Cx50, and caveolin-1, phosphorylates Cx50 at serines and threonines, and Cx46 only at threonines, leading to decreased Cx50 channel density in gap junctions and increased Cx50 hemichannels in plasma membrane.\",\n      \"method\": \"Freeze-fracture immunolabeling (FRIL), dye-transfer assay, PKCγ activity assay, connexin phosphorylation, co-immunoprecipitation\",\n      \"journal\": \"Investigative Ophthalmology & Visual Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods; direct kinase activity, phosphorylation and structural imaging\",\n      \"pmids\": [\"16123426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The SCA14 H101Q mutation in PRKCG causes decreased PKCγ protein levels in HEK293 cells over time (affecting stability/solubility), leading to reduced PKCγ-dependent phosphorylation and slowly progressive cerebellar ataxia.\",\n      \"method\": \"Transfection of HEK293 cells with normal or mutant construct, time-dependent protein level measurements by Western blot\",\n      \"journal\": \"Journal of Human Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional study in transfected cells; single lab\",\n      \"pmids\": [\"16189624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PKCγ interneurons of the spinal dorsal horn are activated by myelinated afferents (VGLUT1-expressing) that respond to innocuous stimuli, not by unmyelinated nociceptors. VGLUT1 synapses were shown pre-synaptic to PKCγ interneurons by electron microscopy, and walking on a rotarod induced Fos in PKCγ interneurons.\",\n      \"method\": \"Transganglionic tracer studies (cholera toxin B, wheat germ agglutinin), transneuronal tracer, light and electron microscopic double labeling, VGLUT1 immunohistochemistry, Fos induction assay\",\n      \"journal\": \"The Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal anatomical methods, electron microscopy, functional Fos assay\",\n      \"pmids\": [\"18685019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NMDAR/nNOS cascade activated by morphine provides free zinc ions that recruit inactive PKCγ (via its C1/CRD domain) to the HINT1/RGSZ complex at the C-terminus of the mu-opioid receptor (MOR). DAG then activates this PKCγ to phosphorylate the MOR, reducing its signaling strength. HINT1 knockdown abolishes PKCγ-MOR association and serine phosphorylation of MOR.\",\n      \"method\": \"Intracerebroventricular administration, co-immunoprecipitation, antisense knockdown of HINT1, zinc chelation (TPEN), NMDAR antagonist (MK801), NO donor experiments\",\n      \"journal\": \"Cellular Signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP, pharmacological epistasis, multiple conditions; single lab\",\n      \"pmids\": [\"18652891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Activation of PKCγ by phorbol ester potentiates AMPA receptor-mediated mEPSC amplitude in embryonic zebrafish via NSF- and PICK1-dependent AMPAR trafficking. This process requires DAG, Ca2+, active PKCγ, actin polymerization, SNARE proteins, and GluR2 association with both NSF and PICK1.\",\n      \"method\": \"Whole-cell patch-clamp recordings, pharmacological blockade with blocking peptides (NSF, PICK1, GluR2), actin-polymerization blocker, tetanus toxin\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiology with multiple peptide/pharmacological tools; zebrafish ortholog\",\n      \"pmids\": [\"19366675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"VEGF activates PKCγ through a Src-dependent PLD1 pathway in human retinal microvascular endothelial cells. Inhibition of Src, PLD1, or PKCγ via pharmacologic, dominant negative, or siRNA approaches significantly attenuated VEGF-induced endothelial cell migration, proliferation, and tube formation, as well as hypoxia-induced retinal neovascularization.\",\n      \"method\": \"siRNA knockdown, dominant negative mutants, pharmacological inhibitors, endothelial cell migration/proliferation/tube formation assays, in vivo retinal neovascularization model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal inhibition strategies (pharmacological, dominant negative, siRNA) with in vitro and in vivo validation\",\n      \"pmids\": [\"20421451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Mutant PKCγ (S119P) associated with SCA14 aggregates in Purkinje cells, impairs climbing fiber synapse pruning, blocks long-term depression (LTD) at parallel fiber synapses, and increases slow EPSC amplitude. Mutant PKCγ colocalizes with and acts in a dominant-negative manner on wild-type PKCγ, and decreases membrane residence time of PKCα after depolarization-induced translocation.\",\n      \"method\": \"Lentiviral expression of mutant PKCγ-GFP in mouse Purkinje cells in vivo, electrophysiology (LTD, EPSCs, CF synapse pruning), immunohistochemistry\",\n      \"journal\": \"The Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo loss/gain of function with electrophysiological and morphological readouts, multiple mechanisms identified\",\n      \"pmids\": [\"21976518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Mutant PKCγ causing SCA14 is selectively degraded by autophagy. Rapamycin (autophagic inducer) accelerated clearance of mutant (but not wild-type) PKCγ aggregates, an effect absent in Atg5-deficient cells that cannot perform autophagy.\",\n      \"method\": \"Adenoviral tetracycline-regulated expression system, rapamycin and lithium treatment, Atg5-knockout fibroblasts as genetic control, aggregate clearance and protein degradation assays\",\n      \"journal\": \"Genes to Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic (Atg5 KO) and pharmacological validation in cell models\",\n      \"pmids\": [\"20398063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PKCγ is required for ethanol-induced increases in GABA(A) receptor α4 subunit expression in cultured cortical neurons. PKCγ siRNA knockdown prevented ethanol-induced α4 upregulation, while PKCβ isoform inhibition had no effect.\",\n      \"method\": \"siRNA knockdown of PKCγ vs PKCβ pseudosubstrate inhibition, P2 fractionation, surface biotinylation, whole-cell patch clamp\",\n      \"journal\": \"Journal of Neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — isoform-selective siRNA knockdown with functional assay and electrophysiology\",\n      \"pmids\": [\"21155805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NO-released zinc ions recruit both Raf-1 and PKCγ via their cysteine-rich domains (CRDs) simultaneously to HINT1 at the MOR C-terminus. PKCγ enhances Raf-1 function to amplify MEK/ERK1/2 activation at the MOR. Morphine-generated NO mediates this cross-talk between PKC/Src and Raf-1/ERK1/2 pathways implicated in negative control of morphine effects.\",\n      \"method\": \"Co-immunoprecipitation, TPEN zinc chelation, MK801 NMDAR blockade, A-Raf/B-Raf comparison, in vivo intracerebroventricular administration\",\n      \"journal\": \"Antioxidants & Redox Signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP with multiple pharmacological controls; single lab\",\n      \"pmids\": [\"21235400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"cPLA2 is an effector downstream of Src-PLD1-PKCγ signaling in VEGF-induced retinal angiogenesis. Inhibition of Src, PLD1, or PKCγ attenuated VEGF-induced cPLA2 phosphorylation and arachidonic acid release, and exogenous arachidonic acid rescued endothelial function from cPLA2 siRNA inhibition.\",\n      \"method\": \"siRNA knockdown, pharmacological inhibition, cPLA2 phosphorylation assay, arachidonic acid release assay, in vivo retinal neovascularization model\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ordered epistasis by siRNA and rescue experiment, in vitro and in vivo\",\n      \"pmids\": [\"21536681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PKCγ participates in food-mediated circadian entrainment by stabilizing BMAL1 and reducing its ubiquitylation in a deubiquitination-dependent manner. PKCγ-null mice failed to show reduced late-night activity in response to daytime restricted feeding, and PKCγ exhibited food-entrainment-induced activation changes in cerebral cortex.\",\n      \"method\": \"PKCγ knockout mice, behavioral analysis, molecular analysis of clock gene oscillations, BMAL1 stability and ubiquitylation assays\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO phenotype with molecular mechanism (BMAL1 stabilization); single lab\",\n      \"pmids\": [\"23185022\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PKCγ directly phosphorylates βPIX (Pak-interacting exchange factor-β) at Ser583 and indirectly at Ser340 in cells, and this phosphorylation is required for Ca2+-evoked dopamine release in the striatum. PKCγ-KO mice show parkinsonian syndrome with impaired striatal dopamine release.\",\n      \"method\": \"PKCγ-KO mice, phosphoproteome analysis, in vitro kinase assay (direct phosphorylation), βPIX knockdown with rescue by wild-type vs phospho-site mutants, Ca2+-evoked dopamine release assay in PC12 cells\",\n      \"journal\": \"The Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct in vitro kinase assay with mutagenesis, in vivo KO phenotype, and rescue experiment\",\n      \"pmids\": [\"25009260\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"EGF activates PLCγ1, which signals through Ca2+ and PKCγ to promote plasma membrane translocation of Hsp90α. PKCγ overexpression increases extracellular vesicle release containing Hsp90α and promotes tumor cell motility and metastasis in vitro and in vivo; a neutralizing antibody against Hsp90α blocks these PKCγ-induced effects.\",\n      \"method\": \"siRNA knockdown, PKCγ overexpression, inhibitor studies, in vitro migration assays, in vivo tumor metastasis model, neutralizing antibody\",\n      \"journal\": \"Traffic\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple inhibition and overexpression strategies; single lab\",\n      \"pmids\": [\"24899266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PKCγ was identified as an amyloidogenic protein capable of forming amyloid-like fibrils in vitro without heat or chemical denaturants, via its C1A and kinase domains. SCA14-associated mutations accelerate amyloid-like fibril formation both in cells and in vitro, and long-term imaging shows aggregates of mutant PKCγ are highly toxic to neuronal cells.\",\n      \"method\": \"In vitro incubation without denaturants, overexpression in cultured cells, live cell time-lapse imaging, identification of amyloid-prone domains by domain deletion\",\n      \"journal\": \"Human Molecular Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of fibril formation with domain mapping and cell toxicity validation\",\n      \"pmids\": [\"25217572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"LysoPCs activate PKCγ through a sequential Hck→PKCδ→PKCγ cascade: Hck causes Tyr311/Tyr525 phosphorylation and Thr507 phosphorylation of PKCδ; activated PKCδ then causes Tyr514 and Ser phosphorylation of PKCγ; activated PKCγ then causes phosphorylation and membrane translocation of p47phox. PKCγ-KO PMNs failed to show PKCδ-PKCγ FRET interaction or priming by lysoPCs.\",\n      \"method\": \"Immunoprecipitation, FRET (fluorescence resonance energy transfer), immunoblotting, specific kinase inhibitors, PKCγ KO mice, TRALI in vivo model, intracellular PKC isoform depletion\",\n      \"journal\": \"Journal of Leukocyte Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — FRET-confirmed protein interaction, genetic KO validation, ordered pathway with phospho-site identification\",\n      \"pmids\": [\"27531930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SCA14 mutations in the C1 domain of PKCγ (H36R and H101Q) cause cytoplasmic mislocalization, aggregation, and hyper-activation of PKCγ (increased substrate phosphorylation). PKCγ aggregates are not efficiently targeted for degradation. Both loss-of-function and gain-of-function mechanisms contribute to SCA14 pathogenesis.\",\n      \"method\": \"Patient-derived iPSCs, post-mortem SCA14 cerebellum, immunohistochemistry, substrate phosphorylation assays, protein localization studies\",\n      \"journal\": \"Acta Neuropathologica Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — patient material (post-mortem and iPSCs) with functional phosphorylation assays, two mutations studied\",\n      \"pmids\": [\"30249303\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Endogenous Hsp70 is incorporated into SCA14-associated PKCγ aggregates. PKCγ binds Hsp70 via its kinase domain and C2 domain, with enhanced interaction in SCA14 mutants. Pharmacological up-regulation of Hsp70 (by Hsp90 inhibitors celastrol/herbimycin A) attenuates mutant PKCγ aggregation and apoptosis in Purkinje cells.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, primary cultured Purkinje cells, Hsp90 inhibitor treatment, apoptosis assay, in vivo celastrol administration\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP with domain mapping and functional rescue; single lab\",\n      \"pmids\": [\"30093405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PKCγ promotes axonal remodeling in the corticospinal tract by phosphorylating GSK3β, which stabilizes cytosolic β-catenin and increases GAP43 expression, facilitating neuronal differentiation, neurite outgrowth, and axonal branching. In vivo rAAV2/9-mediated delivery of constitutively active PKCγ to CST after unilateral TBI promoted midline crossing of corticospinal fibers and sensorimotor recovery.\",\n      \"method\": \"Loss- and gain-of-function in N2a cells and primary cortical neurons, GSK3β phosphorylation assays, β-catenin and GAP43 Western blot, rAAV2/9 in vivo delivery, axonal tracing, behavioral assays\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — signaling pathway epistasis with in vitro and in vivo validation; single lab\",\n      \"pmids\": [\"31745212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ΔNp63α positively regulates miR-320a, which suppresses PKCγ expression. Loss of ΔNp63α elevates PKCγ levels, increasing Rac1 phosphorylation at Ser71 and cell invasion. Silencing PKCγ or inhibiting PKC reversed increased Rac1 phosphorylation and invasion caused by ΔNp63α knockdown.\",\n      \"method\": \"siRNA knockdown, miRNA mimic overexpression, PKC inhibitor (Gö6976), Rac1 silencing, invasion assays\",\n      \"journal\": \"Cell Death & Disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ordered pathway validated by multiple knockdown strategies; single lab\",\n      \"pmids\": [\"31515469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DGKγ directly interacts with PKCγ, converts diacylglycerol to phosphatidic acid, and thereby negatively regulates PKCγ activity. DGKγ knockout mice show upregulated PKCγ activity in cerebellum, impaired cerebellar LTD, retracted Purkinje cell dendrites, and impaired motor coordination. cPKC inhibitor rescues dendritic retraction; PKCγ-specific inhibitor (scutellarin) rescues LTD.\",\n      \"method\": \"DGKγ KO mice, Purkinje cell-specific DGKγ KO (tm1d), PKCγ activity assays, cerebellar LTD electrophysiology, dendritic morphology analysis, rescue with Gö6976 and scutellarin, FLP-mediated re-expression rescue\",\n      \"journal\": \"eNeuro\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic models (conventional and conditional KO, re-expression), pharmacological rescue, electrophysiology\",\n      \"pmids\": [\"32033984\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"AMPKα1 inhibits PKCγ kinase activity, thereby decreasing phosphorylation and membrane translocation of Hsp90α and suppressing tumor metastasis. Metformin activates AMPKα1 to inhibit PKCγ-mediated Hsp90α secretion.\",\n      \"method\": \"Mass spectrometry, AMPKα1 overexpression/knockdown, PKCγ kinase activity assay, Hsp90α phosphorylation and secretion assays, in vitro migration/invasion, in vivo metastasis model\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — kinase activity assay with upstream regulator and downstream phosphorylation; single lab\",\n      \"pmids\": [\"31936169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PKCγ-mediated phosphorylation of CRMP2 at Thr555 regulates dendritic outgrowth in cerebellar Purkinje cells. Immunoprecipitation-MS identified CRMP2 as a PKCγ(S361G)-interacting protein; Thr555 phosphorylation is increased in PKCγ(S361G) transgenic Purkinje cells. CRMP2 knockdown and Thr555 site mutants reduce dendritic outgrowth; a T555A knock-in mouse shows reduced dendritic development.\",\n      \"method\": \"Immunoprecipitation-coupled mass spectrometry, Duolink proximity ligation assay, cerebellar slice cultures, miRNA knockdown, phospho-site mutagenesis, T555A knock-in mouse\",\n      \"journal\": \"Molecular Neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — MS-identified substrate, confirmed by proximity ligation, phospho-site mutagenesis, and knock-in mouse\",\n      \"pmids\": [\"32860158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A pseudosubstrate domain knock-in mutation (A24E) in PKCγ causes constitutive activation of the kinase domain while also promoting dephosphorylation and protein degradation, resulting in dramatically reduced PKCγ protein levels but increased PKC activity. Purkinje cells show short thickened dendrites typical of PKC activation, and mice develop marked ataxia.\",\n      \"method\": \"Knock-in mouse model, PKCγ expression measurement by Western blot, PKC activity assay in Purkinje cells, dendritic morphology analysis, behavioral ataxia testing, RNA profiling\",\n      \"journal\": \"The Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knock-in genetic model with kinase activity measurement and morphological/behavioral readouts\",\n      \"pmids\": [\"33478986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TRPM2 directly associates with PKCγ via the C2 domain of PKCγ binding to the M2PBM motif on TRPM2. TRPM2-mediated Ca2+ influx promotes PKCγ activation, which subsequently enhances TRPM2-induced potentiation of extrasynaptic NMDAR activity, amplifying excitotoxic neuronal death. Disrupting this interaction with a TAT-M2PBM interfering peptide reduces excitotoxicity and ischemic brain injury.\",\n      \"method\": \"Identification of interaction motif, co-immunoprecipitation, interfering peptide (TAT-M2PBM), M2PBM deletion constructs, extrasynaptic NMDAR electrophysiology, ischemic stroke models\",\n      \"journal\": \"Cell Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — interaction domain mapped, co-IP validated, interfering peptide with functional and in vivo rescue\",\n      \"pmids\": [\"38308841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SCA14 mutation V138E in PKCγ C1B domain causes partial unfolding of the protein with exposed C-terminus (shown by FRET-FLIM), faster phorbol ester-induced membrane translocation, and accumulation of fully phosphorylated PKCγ in the insoluble fraction. Co-expression of PDK1 (which triggers PKCγ autophosphorylation) rescues the PKCγ-V138E insolubilization phenotype.\",\n      \"method\": \"FRET-fluorescence lifetime imaging microscopy (FRET-FLIM) in living cells, phorbol ester-induced translocation assay, phosphorylation state analysis, PDK1 co-expression rescue\",\n      \"journal\": \"Journal of Neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — FRET-FLIM structural evidence plus functional rescue by PDK1; multiple methods\",\n      \"pmids\": [\"24134140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Glycine inhibitory dysfunction activates a local circuit involving PKCγ-expressing interneurons in the superficial dorsal horn to convert touch into pain. Selective inhibition of PKCγ as well as selective blockade of NMDA receptors in the superficial dorsal horn prevented activation of this circuit and allodynia, establishing PKCγ as required for NMDA-receptor-dependent gating of tactile input to nociceptive neurons.\",\n      \"method\": \"In vivo electrophysiology, segmental glycine inhibition removal (strychnine), anatomical circuit tracing, pharmacological PKCγ inhibition, NMDA receptor antagonism\",\n      \"journal\": \"PLoS ONE\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiology with pharmacological epistasis; single lab\",\n      \"pmids\": [\"17987109\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PKCγ (PRKCG) is a calcium- and DAG-dependent serine/threonine kinase that, upon activation, translocates to membranes where it phosphorylates diverse substrates including connexins (Cx43, Cx50), syndecan-2, CRMP2, βPIX, and the mu-opioid receptor; it is regulated by 14-3-3ε (inhibitory), DGKγ (limiting DAG availability), Hsp70 (chaperone), and AMPKα1 (inhibitory kinase), and operates in multiple signaling axes including Src-PLD1-PKCγ-cPLA2 in angiogenesis, NMDAR/nNOS/zinc-HINT1 at opioid receptors, and GSK3β/β-catenin in axonal growth; in the spinal cord, PKCγ interneurons are activated by myelinated low-threshold afferents and gate tactile input to nociceptive circuits underlying mechanical allodynia, while in cerebellar Purkinje cells PKCγ regulates climbing fiber synapse pruning, LTD, and dendritic development, and SCA14-causing mutations in the C1 domain cause PKCγ misfolding, amyloid-like aggregation, hyper-activation or loss of function, and Purkinje cell degeneration.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PKCγ (PRKCG) is a calcium- and diacylglycerol-dependent serine/threonine kinase that functions as a critical signaling node in neuronal circuit development, synaptic plasticity, pain processing, and diverse non-neuronal signaling pathways. In cerebellar Purkinje cells, PKCγ phosphorylates CRMP2 at Thr555 to regulate dendritic outgrowth, controls climbing fiber synapse pruning and long-term depression (LTD), and is negatively regulated by DGKγ-mediated DAG consumption, 14-3-3ε binding to its C1B domain, and AMPK α1-mediated inhibition [PMID:32860158, PMID:32033984, PMID:15459208, PMID:31936169]. In the spinal dorsal horn, PKCγ-expressing interneurons receive myelinated low-threshold mechanoreceptor input and gate tactile signals into nociceptive circuits; PKCγ-null mice lack neuropathic pain and fail to sustain NMDA-dependent hyperexcitability after tissue injury [PMID:9323205, PMID:18685019, PMID:11438608]. Missense mutations in the C1 domain of PRKCG cause spinocerebellar ataxia type 14 (SCA14), in which PKCγ undergoes misfolding, amyloid-like aggregation, and combined gain- and loss-of-function that drives Purkinje cell degeneration [PMID:25217572, PMID:30249303, PMID:21976518].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"The question of whether PKCγ is required for pain sensation was resolved: PKCγ-null mice retained normal acute nociception but completely failed to develop neuropathic pain, establishing PKCγ as selectively required for injury-induced pain sensitization rather than baseline pain processing.\",\n      \"evidence\": \"PKCγ knockout mouse with behavioral pain testing across multiple paradigms\",\n      \"pmids\": [\"9323205\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream substrates mediating the pain-gating function were unknown\", \"The circuit position of PKCγ interneurons relative to afferent types was not determined\", \"Mechanism of transition from acute to persistent hyperexcitability was unclear\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"PKCγ was shown to mediate the transition from short-lived to persistent spinal hyperexcitability via NMDA-dependent circuits, explaining why neuropathic pain requires PKCγ while acute pain does not.\",\n      \"evidence\": \"Electrophysiology of wide dynamic range neurons in PKCγ-null versus wild-type mice with NMDA antagonist epistasis\",\n      \"pmids\": [\"11438608\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the afferent inputs activating PKCγ interneurons was unresolved\", \"Direct phosphorylation substrates in the spinal pain circuit were unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"PKCγ was demonstrated to function outside the nervous system as a direct kinase for syndecan-2, establishing asymmetric phosphorylation as a mechanism for left-right axis determination during Xenopus gastrulation.\",\n      \"evidence\": \"In vivo phosphorylation assays with dominant-negative and constitutively active PKCγ constructs in Xenopus ectodermal cells\",\n      \"pmids\": [\"12507425\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this developmental role is conserved in mammals was not tested\", \"The upstream signal generating asymmetric PKCγ activation was not identified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"PKCγ was identified as the kinase responsible for connexin phosphorylation and gap junction regulation in lens cells, revealing a DAG-dependent (calcium-independent) activation mode downstream of IGF-I signaling.\",\n      \"evidence\": \"Co-immunoprecipitation, in vitro kinase assay, and scrape-loading dye-transfer in lens epithelial cells\",\n      \"pmids\": [\"12601045\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific phosphorylation sites on Cx43 were not mapped\", \"Whether other connexins (Cx50, Cx46) were similarly regulated was not yet tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"14-3-3ε was established as an endogenous inhibitor that sequesters PKCγ via its C1B domain, and competitive release of PKCγ from 14-3-3ε was shown to trigger membrane translocation, Cx43 phosphorylation, and gap junction closure, revealing a discrete regulatory mechanism controlling PKCγ activation state.\",\n      \"evidence\": \"Synthetic peptide competition binding assays, co-IP, MALDI-TOF MS for binding sites, and functional gap junction assays\",\n      \"pmids\": [\"15459208\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of 14-3-3ε regulation of PKCγ was not demonstrated\", \"Whether 14-3-3ε regulates PKCγ in neurons was unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"The first SCA14 mutations in PKCγ were functionally characterized: the H101Q mutation reduced PKCγ protein stability and the S119P mutation caused aggregation in Purkinje cells with dominant-negative effects on wild-type PKCγ, LTD blockade, and impaired climbing fiber synapse pruning, linking PKCγ misfolding to cerebellar degeneration.\",\n      \"evidence\": \"HEK293 transfection (H101Q), lentiviral expression in mouse Purkinje cells in vivo (S119P) with electrophysiology and morphological analysis\",\n      \"pmids\": [\"16189624\", \"21976518\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether aggregation or loss of kinase function was the primary pathogenic driver was unresolved\", \"In vitro reconstitution of aggregation had not been achieved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"A spinal circuit mechanism was elucidated: disinhibition (loss of glycinergic tone) activates PKCγ interneurons to gate touch into the nociceptive pathway via NMDA receptor-dependent signaling, establishing PKCγ as the molecular switch for mechanical allodynia.\",\n      \"evidence\": \"In vivo electrophysiology with strychnine disinhibition, pharmacological PKCγ inhibition, and NMDA antagonism\",\n      \"pmids\": [\"17987109\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The specific afferent fiber type driving PKCγ interneurons was not yet anatomically defined\", \"Downstream targets of PKCγ in this circuit were not identified\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The afferent input to PKCγ interneurons was anatomically resolved: VGLUT1-positive myelinated low-threshold mechanoreceptors (not unmyelinated nociceptors) synapse directly onto PKCγ interneurons, explaining how touch signals access pain circuits after disinhibition. Separately, PKCγ was recruited to the mu-opioid receptor via HINT1/zinc-dependent scaffolding to phosphorylate MOR and attenuate opioid signaling.\",\n      \"evidence\": \"Electron microscopic double labeling and VGLUT1 immunohistochemistry (afferent identity); co-IP with HINT1 knockdown and zinc chelation (MOR pathway)\",\n      \"pmids\": [\"18685019\", \"18652891\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PKCγ phosphorylation of MOR is direct was not shown by in vitro kinase assay\", \"The full circuit downstream of PKCγ interneurons to projection neurons was not mapped\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"PKCγ was positioned within the Src→PLD1→PKCγ→cPLA2 signaling axis driving VEGF-induced retinal angiogenesis, demonstrating a non-neuronal role in endothelial cell migration, proliferation, and neovascularization, while SCA14 mutant PKCγ was shown to be selectively cleared by autophagy.\",\n      \"evidence\": \"Multiple inhibition strategies (siRNA, dominant-negative, pharmacological) with in vitro and in vivo retinal models; Atg5-KO fibroblasts for autophagy dependence\",\n      \"pmids\": [\"20421451\", \"21536681\", \"20398063\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PKCγ phosphorylation of cPLA2 was not demonstrated by in vitro kinase assay\", \"Whether autophagy clearance of mutant PKCγ is sufficient to prevent neurodegeneration in vivo was untested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"FRET-FLIM revealed that SCA14 C1B domain mutations cause partial unfolding of PKCγ with an exposed C-terminus, accelerated membrane translocation, and accumulation of fully phosphorylated protein in the insoluble fraction, providing a structural basis for how point mutations drive both hyperactivation and aggregation.\",\n      \"evidence\": \"FRET-fluorescence lifetime imaging in living cells with PDK1 co-expression rescue of insolubilization\",\n      \"pmids\": [\"24134140\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution structural data for the misfolded state was lacking\", \"Whether PDK1 rescue is therapeutically exploitable was unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"PKCγ was identified as a direct kinase for βPIX at Ser583, linking PKCγ to Ca²⁺-evoked dopamine release in the striatum; PKCγ-null mice develop parkinsonian syndrome, broadening PKCγ's neurological roles beyond pain and cerebellar function. PKCγ amyloid-like fibril formation was reconstituted in vitro from the C1A and kinase domains, with SCA14 mutations accelerating fibrillization.\",\n      \"evidence\": \"In vitro kinase assay with phospho-site mutagenesis and rescue in PKCγ-KO mice; cell-free fibril formation assay with domain deletion mapping\",\n      \"pmids\": [\"25009260\", \"25217572\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether βPIX phosphorylation is the sole mechanism for dopamine release regulation was not tested\", \"The amyloid fibril structure was not resolved at atomic level\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"A sequential kinase cascade (Hck→PKCδ→PKCγ) was defined for lysoPC-mediated neutrophil priming, with PKCγ phosphorylating p47phox to enable NADPH oxidase activation, establishing PKCγ as an effector in innate immune priming.\",\n      \"evidence\": \"FRET-confirmed PKCδ–PKCγ interaction, phospho-site identification, PKCγ-KO PMNs, in vivo TRALI model\",\n      \"pmids\": [\"27531930\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PKCγ directly phosphorylates p47phox was not shown by in vitro kinase assay\", \"Relevance to human neutrophil biology was not confirmed\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Analysis of patient-derived iPSCs and post-mortem SCA14 cerebellum confirmed that C1 domain mutations cause both gain-of-function (hyperphosphorylation of substrates) and loss-of-function (aggregation/mislocalization) in human tissue, while Hsp70 was identified as a chaperone that binds PKCγ's kinase and C2 domains and can be pharmacologically upregulated to attenuate aggregation and apoptosis.\",\n      \"evidence\": \"Patient iPSCs, post-mortem immunohistochemistry, substrate phosphorylation assays; co-IP domain mapping, celastrol/herbimycin A rescue in primary Purkinje cells\",\n      \"pmids\": [\"30249303\", \"30093405\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Hsp70 upregulation is neuroprotective in vivo in SCA14 models was not shown\", \"The relative contribution of gain- versus loss-of-function to disease progression remained unquantified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"DGKγ was established as a direct negative regulator of PKCγ in Purkinje cells by metabolizing DAG to phosphatidic acid; DGKγ-KO mice phenocopy PKCγ hyperactivation with impaired LTD and dendritic retraction, rescued by PKCγ-specific inhibition. CRMP2 was identified by IP-MS as a direct PKCγ substrate phosphorylated at Thr555 to regulate Purkinje cell dendritic outgrowth, confirmed by a T555A knock-in mouse.\",\n      \"evidence\": \"Conditional DGKγ KO with pharmacological rescue; IP-MS substrate identification, proximity ligation, phospho-site mutagenesis, T555A knock-in mouse\",\n      \"pmids\": [\"32033984\", \"32860158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Additional PKCγ substrates in Purkinje cells likely remain unidentified\", \"How CRMP2 phosphorylation interacts with other PKCγ-dependent dendritic signals was not tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"A pseudosubstrate domain knock-in (A24E) proved that constitutive PKCγ kinase activation paradoxically leads to protein degradation and reduced steady-state levels while still driving aberrant Purkinje cell morphology and ataxia, clarifying that even transient hyperactivation is pathogenic.\",\n      \"evidence\": \"A24E knock-in mouse with PKC activity measurement, dendritic morphology, and behavioral analysis\",\n      \"pmids\": [\"33478986\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The degradation pathway (proteasomal vs. autophagic) for constitutively active PKCγ was not defined\", \"Whether pharmacological dampening of PKCγ activity could rescue the A24E phenotype was not tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"TRPM2 was identified as a direct PKCγ-interacting partner via the C2 domain–M2PBM interface, establishing a feedforward loop: TRPM2-mediated Ca²⁺ influx activates PKCγ, which then potentiates extrasynaptic NMDAR activity to amplify excitotoxicity. An interfering peptide disrupting this interaction was neuroprotective in ischemic stroke models.\",\n      \"evidence\": \"Interaction motif mapping, co-IP, TAT-M2PBM interfering peptide, extrasynaptic NMDAR electrophysiology, ischemic stroke models in vivo\",\n      \"pmids\": [\"38308841\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PKCγ directly phosphorylates TRPM2 or NMDARs was not determined\", \"Long-term efficacy and specificity of TAT-M2PBM in vivo were not assessed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the full repertoire of PKCγ substrates in spinal dorsal horn pain circuits, the atomic-resolution structure of PKCγ and its SCA14 aggregates, the relative therapeutic value of targeting gain-of-function versus loss-of-function mechanisms in SCA14, and how PKCγ signaling is coordinated across its diverse neuronal and non-neuronal contexts.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No substrate identified in spinal PKCγ interneurons\", \"No high-resolution structure of full-length PKCγ or its amyloid fibrils\", \"No clinical trial data for PKCγ-targeted therapies in SCA14 or neuropathic pain\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [2, 3, 5, 17, 27, 29]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [3, 4, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 5, 18, 29]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4, 21, 30]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 8, 10, 14, 15, 20, 23, 29]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 1, 7, 9, 29, 31]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [6, 11, 19, 21, 28, 30]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 25, 27]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"YWHAE\",\n      \"HINT1\",\n      \"DGKG\",\n      \"DPYSL2\",\n      \"ARHGEF7\",\n      \"TRPM2\",\n      \"HSPA1A\",\n      \"GJA1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}